Viruses use stealth technology to escape from the host immune system

Molecular Medicine Today

Volumn 3, Issue 3, 1997, Pages 116-123

  Wiertz, Emmanuel J H J ^a   Mukherjee, Siddhartha ^a   Ploegh, Hidde L ^a  

^a MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

ADENOVIRUS; DRUG TARGETING; EPSTEIN BARR VIRUS; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; NONHUMAN; REVIEW; VIRUS INFECTION;

ADENOVIRIDAE; ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, VIRAL; CYSTEINE ENDOPEPTIDASES; ENDOPLASMIC RETICULUM; EPITOPES; GENE EXPRESSION REGULATION, VIRAL; HERPESVIRIDAE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNOLOGIC SURVEILLANCE; MICE; MODELS, IMMUNOLOGICAL; MULTIENZYME COMPLEXES; PROTEASOME ENDOPEPTIDASE COMPLEX; REPETITIVE SEQUENCES, NUCLEIC ACID; T-LYMPHOCYTES, CYTOTOXIC; VIRUSES;

ADENOVIRIDAE; CYTOMEGALOVIRUS; HERPES; HUMAN HERPESVIRUS 4; HUMAN HERPESVIRUS 5; SIMPLEXVIRUS;

EID: 0031084807     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1357-4310(96)10059-9     Document Type: Review

References (52)

1. 1 Zinkernagel, R.M. et al. (1979) MHC-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness, Adv. Immunol. 27, 51-57
2. 2 Zinkernagel, R.M. (1996) Immunology taught by viruses, Science 271, 173-178
3. 3 Maudsley, D.J. and Pound, J.D. (1991) Modulation of MHC antigen expression by viruses and oncogenes, Immunol. Today 12, 429-431
4. 4 Hill, A. and Ploegh, H.L. (1995) Getting the inside out: TAP and the presentation of viral antigen, Proc. Natl. Acad. Sci. U. S. A. 92, 341-343
5. 5 Coux, O., Tanaka, K. and Goldberg, A.L. (1996) Structure and functions of the 20S and 26S proteasomes, Annu. Rev. Biochem. 65, 801-847
6. 6 Heemels, M-T. and Ploegh, H.L. (1995) Generation, translocation and presentation of MHC class I-restricted peptides, Annu. Rev. Biochem. 64, 463-491
7. 7 Townsend, A. and Bodmer, H. (1989) Antigen recognition by class I restricted T-lymphocytes, Annu. Rev. Immunol. 7, 601-624
8. 8 Jorgensen, J.L., Reay, P.A., Ehrich, E.W. and Davis, M.M. (1992) Molecular components of T-cell recognition, Annu. Rev. Immunol. 10, 835-873
9. + T lymphocytes, Cell 77, 525-535
10. 10 Früh, K. et al. (1995) A viral inhibitor of peptide transporters for antigen presentation, Nature 375, 415-418
11. 11 Hill, A. et al. (1995) Herpes simplex virus turns off the TAP to evade host immunity, Nature 375, 411-415
12. 12 Tomazin, R. et al. (1996) Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP, EMBO J. 15, 3256-3266
13. 13 Heemels, M-T., Schumacher, T.N.M., Wonegeit, K. and Ploegh, H. (1993) Different peptides are translocated by allelic variants of the transporter associated with antigen presentation (TAP), Science 262, 2059-2063
14. 14 Reusser, P. et al. (1991) Cytotoxic T lymphocyte responses to cytomegalovirus after human allogeneic bone marrow transplantation: pattern of recovery and correlation with cytomegalovirus infection and disease, Blood 78, 1373-1380
15. 15 Quinnan, G.V. et al. (1982) Cytotoxic T cells in cytomegalovirus infection: HLA-restricted T lymphocyte and non-T lymphocyte cytotoxic responses correlate with recovery from cytomegalovirus in bone marrow transplant recipients, New Engl. J. Med 307, 6-13
16. 16 Beersma, M.F.C., Bijlmakers, M.J.E. and Ploegh, H.L. (1993) Human cytomegalovirus down-regulates HLA class I expression by reducing the stability of class I H chains, J. Immunol. 151, 4455-4464
17. 17 Warren, A.P., Ducroq, D.H., Lehner, P.J. and Borysiewicz, L.K. (1994) Human cytomegalovirus-infected cells have unstable assembly of major histocompatibility complex class I complexes and are resistant to lysis by cytotoxic T lymphocytes, J. Virol. 68, 2822-2829
18. 18 Jones, T.R. et al. (1995) Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains, J. Virol. 69, 4830-4841
19. 19 Wiertz, E.J.H.J. et al. (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol, Cell 84, 769-779
20. 20 Wiertz, E.J.H.J. et al. Sec61-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction, Nature (in press)
21. 21 Jones, T.R. et al. Human cytomegalovirus US3 impairs transport and maturation of MHC class I heavy chains. Proc. Natl. Acad. Sci. U. S. A. (in press)
22. 22 Ahn, K. et al. Human cytomegalovirus inhibits antigen presentation by a sequential multistep process, Proc. Natl. Acad. Sci. U. S. A. (in press)
23. 23 Beck, S. and Barrell, B.G. (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens, Nature 331, 269-272
24. 2 microglobulin, Nature 347, 770-772
25. 25 Browne, H. et al. (1992) Construction and characterization of a human cytomegalovirus mutant with the UL18 (class I homolog) gene deleted, J. Virol. 66, 6784-6787
26. 26 Koszinowski, U., Reddehase, M.J. and Del Val, M. (1992) Principles of cytomegalovirus antigen presentation in vitro and in vivo, Semin. Immunol. 4, 71-79
27. 27 Scalzo, A.A. et al. (1995) Genetic mapping of CMV1 in the region of the mouse chromosome 6 encoding the NK gene complex associated loci Ly49 and musNKR-P1, Genomics 27, 435-441
28. 28 Campbell, A.E., Slater, J.S., Cavanaugh, V.J. and Stenberg, R.M. (1992) An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes, J Virol. 66, 3011-3017
29. 29 Del Val, M. et al. (1989) Presentation of CMV immediate early antigen to cytolytic T lymphocytes is selectively prevented by viral genes expressed in the early phase, Cell 58, 305-315
30. 30 Del Val, M. et al. (1992) Cytomegalovirus prevents antigen presentation by blocking the transport of peptide-loaded major histocompatibility complex I molecules into the medial-Golgi compartment, J. Exp. Med. 176, 729-738
31. 31 Thale, R. et al. (1995) Identification of the mouse cytomegalovirus genomic region affecting major histocompatibility complex class I molecule transport, J. Virol. 69, 6098-6105
32. 32 Kleijnen, M.F. et al. A mouse cytomegalovirus glycoprotein, gp34, forms a complex with folded class I MHC molecules in the ER which is not retained but transported to the cell surface, EMBO J. (in press)
33. 33 Khanna, R. et al. (1992) Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine development, J. Exp.Med. 176, 169-176
34. 34 Gavioli, R. et al. (1992) Recognition of Epstein-Barr virus-encoded nuclear antigens EBNA-4 and EBNA-6 by HLA-A11-restricted cytotoxic T lymphocytes: implications for down-regulation of HLA-A11 in Burkitt's lymphoma, Proc. Natl. Acad. Sci. U. S. A. 89, 5862-5866
35. 35 Klein, G. (1989) Viral latency and transformation: the strategy of Epstein-Barr virus, Cell 58, 5-8
36. 36 Chen, F. et al. (1995) A subpopulation of normal B cells latently infected with Epstein-Barr virus resembles Burkitt lymphoma cells in expressing EBNA-1 but not EBNA-2 or LMP-1, J. Virol. 69, 3752-3758
37. 37 Stuber, G. et al. (1995) HLA-A0201 and HLA B7 binding petides in EBV-encoded EBNA-1, EBNA-2 and BZLF-1 detected in the MHC class I stabilization assay, Int. Immunol. 7, 653-663
38. 38 Levitskaya, J. et al. (1995) Inhibition of antigen presentation by the internal repeat region of the Epstein-Barr virus nuclear antigen-1, Nature 375, 685-688
39. 39 Shemesh, J. and Ehrlich, R. (1993) Aberrant biosynthesis and transport of class I major histocompatibility complex molecules in cells transformed with highly oncogenic human adenoviruses, J. Biol. Chem. 268, 15704-15711
40. 40 Rotem-Yehudar, R. et al. (1994) Downregulation of peptide transporter genes in cell lines tranformed with highly oncogenic adenovirus 12, J. Exp. Med. 180. 477-488
41. 41 Schouten, G.J., van der Eb, A.J. and Zantema, A. (1995) Down regulation of MHC class I expression due to interference with p105-NFκB1 processing by Ad12E1A, EMBO J. 14, 1498-1507
42. 42 Schrier, P.I. et al. (1983) Expression of class I major histocompatibility antigens switched off by highly oncogenic adenovirus 12 in transformed rat cells, Nature 305, 771-775
43. 43 Bernards, R. et al. (1983) Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity, Nature 305, 776-779
44. 44 Burgert, H.G. and Kvist, S. (1985) An adenovirus type 2 glycoprotein blocks cell surface expression of human histocompatibility class I antigens, Cell 41, 987-997
45. 45 Andersson, M. et al. (1985) Impaired intracellular transport of class I MHC antigens as a possible means of adenoviruses to evade immune surveillance, Cell 43, 215-222
46. 46 Jefferies, W.A. and Burgert, H.G. (1990) E3/19K from adenovirus 2 is an immunosubversive protein that binds to a structural motif regulating the intracellular transport of major histocompatibility complex class I proteins, J. Exp. Med. 172, 1653-1664
47. 47 Rawle, F.C., Tollefson, A.E., Wold, W.S. and Gooding, L.R. (1989) Mouse anti-adenovirus cytotoxic T lymphocytes. Inhibition of lysis by E3 gp19K but not E3 14.7K, J. Immunol. 143, 2031-2037
48. 48 Paabo, S., Bhat, B.M., Wold, W.S.M. and Peterson, P.A. (1987) A short sequence in the COOH-terminus makes an adenovirus membrane glycoprotein a resident of the endoplasmic reticulum, Cell 50, 311-317
49. 49 Cox, J.H., Bennink, J.R. and Yewdell, J.W. (1991) Retention of adenovirus E19 glycoprotein in the endoplasmic reticulum is essential to its ability to block antigen presentation, J. Exp. Med. 174, 1629-1637
50. 50 Smith, G. (1994) Virus strategies for evasion of the host response to infection, Trends Microbiol. 2, 81-88
51. 51 Löwe, J. et al. (1995) Crystal structure of the 20S proteasome from the Archaeon T. acidophilus at 3.4 Å resolution, Science 268, 533-539
52. 52 Goldberg, A.L. et al. Functions of the proteasome in antigen presentation, Cold Spring Harbor Symp. Quant. Biol. 60, 479-490